Patient Compliance

Sweetening the Pill

Faiz Kermani, Madhu Davies

$284

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Gower Publishing Ltd
28 December 2006

Manufacturing industries; Public health & preventive medicine; Health systems & services; Pharmacology; Ergonomics

Vast global resources are ploughed into the delivery of treatment interventions ranging from diet and lifestyle advice to complex surgery. In all cases, whatever the intervention, unless the recipient is engaged with the process and understands why the intervention has been offered and the part they play in its success, compliance is an issue. Even where the individual does engage and understand, he or she may choose not to comply.

Non-compliance is estimated to cost the pharma industry US$70 billion per year. No figures exist for the cost to healthcare insurers and public health but non-compliance is undoubtedly one of the top five issues facing both drug developers and healthcare providers.

During clinical trials, non-compliance undermines the accuracy of the data generated from the whole trial as well as particular aspects such as the efficacy of different dosages.

This book explores the key factors which drive compliance and the part that healthcare professionals can play in improving this, with the key underlying goal of improving public health in its broadest sense.

By: Faiz Kermani
Edited by: Madhu Davies
Imprint: Gower Publishing Ltd
Country of Publication: United Kingdom
Edition: New edition
Dimensions: Height: 297mm, Width: 210mm, Spine: 13mm
Weight: 453g
ISBN: 9780566086588
ISBN 10: 0566086581
Pages: 238
Publication Date: 28 December 2006
Audience: College/higher education , General/trade , Professional & Vocational , Primary , ELT Advanced
Format: Hardback
Publisher's Status: Active

List of Figures and Tables, List of Abbreviations, List of Contributors, Preface, Part 1 What is Compliance?, Part 2 The Challenge of Compliance, Part 3 Building For Success, Part 4 Achieving Compliance: Looking to the Future, Index

Dr Madhu Davies is a consultant in pharmaceutical medicine, and Editor of Pharmaceutical Physician journal. She joined the pharmaceutical industry in 1993 following several years' clinical experience. Dr Faiz Kermani has several years experience in both academia and the pharmaceutical industry. He has worked in pharmaceutical R&D, pricing and reimbursement, marketing and medical education. He holds a PhD in Immunopharmacology from St. Thomas' Hospital, London and a First Class Honours degree in Pharmacology with Toxicology from King's College, London. He has written extensively on international healthcare issues, and is on the editorial board of a number of publications. In March 2006, he was a delegate on the UK Government's Trade and Investment Biotech Scoping Mission to China and contributed to the subsequent report.

Reviews for Patient Compliance: Sweetening the Pill

'I found this particular volume to be very informative, well written, practical, and unbiased...The contributors are an impressive group of experts who are mostly from the United Kingdom but also from the United States, France, Japan, and Australia. This diversity results in an interesting cross-cultural perspective on the issue.' Psychiatric Services, March 2008 (US)